Acomplia (rimonabant), a promising new drug for obesity, smoking cessation, and high cholesterol

November 2004

Researchers are excited about Acomplia (rimonabant), a promising new drug for obesity, smoking cessation, and high cholesterol.

The lay press has picked up on this too-good-to-be-true drug, and people are asking about it.

It's the first in a new class...called selective cannabinoid type 1 (CB1) blockers.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

"Medication Therapy Management" under the new Medicare law
NSAIDs Lots of patients are asking about alternatives to Vioxx
Osteoporosis Do carbonated beverages cause bone loss
Women's Health Diflucan once a WEEK to PREVENT recurrent vaginal yeast infections
Anticoagulants stop warfarin prior to surgery or other invasive procedures
Anticoagulants The new anticoagulant Exanta (ximelagatran) won't be replacing warfarin any time soon
Pediatrics Croup will be treated more frequently with dexamethasone
Pediatrics Nuvo lotion for head lice
Infectious Diseases The flu vaccine shortage will put new emphasis on FluMist and antivirals
Infectious Diseases New treatments are being used for skin infections
Cardiology risk of potentially fatal arrhythmias with erythromycin
Supplements if prickly pear cactus can prevent hangovers
Parcopa, a new carbidopa/levodopa tablet that dissolves on the tongue
Acomplia (rimonabant), a promising new drug for obesity, smoking cessation, and high cholesterol
Gastroenterology Celiac patients need to avoid gluten in foods and drugs